Centessa Pharmaceuticals PLC ADR (CNTA) Insider Trading
- $3,235,137.92
- $16,876,320.90
- March 25, 2025
- Saurabh Saha
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 30, 2022 | Insider | 3,401 | $4.07 | Sell | $13,842.07 | |
| Sept. 30, 2022 | CFO | 4,000 | $4.07 | Sell | $16,280.00 | |
| Sept. 30, 2022 | CTO | 2,003 | $4.07 | Sell | $8,152.21 | |
| Aug. 1, 2022 | EVP | 10,423 | $4.45 | Sell | $46,382.35 | |
| July 18, 2022 | EVP | 20,000 | $4.87 | Sell | $97,400.00 | |
| July 1, 2022 | EVP | 9,100 | $5.03 | Sell | $45,773.00 | |
| June 24, 2022 | CEO | 10,000 | $4.63 | Buy | $46,300.00 | |
| June 17, 2022 | EVP | 9,200 | $4.68 | Sell | $43,056.00 | |
| May 17, 2022 | EVP | 20,222 | $5.42 | Sell | $109,603.24 | |
| Feb. 2, 2022 | CEO | 5,000 | $9.74 | Buy | $48,700.00 | |
| Jan. 28, 2022 | Insider | 27,500 | $9.05 | Buy | $248,875.00 | |
| Dec. 2, 2021 | Major Shareholder | 34,326 | $12.82 | Buy | $440,059.32 | |
| Dec. 1, 2021 | Director | 60,304 | $12.62 | Buy | $761,036.48 | |
| Nov. 30, 2021 | Major Shareholder | 36,847 | $11.62 | Buy | $428,162.14 | |
| Nov. 29, 2021 | Director | 56,706 | $11.70 | Buy | $663,460.20 | |
| Nov. 26, 2021 | Director | 11,817 | $11.34 | Buy | $134,004.78 | |
| Nov. 18, 2021 | Director | 10,000 | $11.98 | Buy | $119,800.00 | |
| Nov. 16, 2021 | Insider | 5,000 | $12.46 | Buy | $62,300.00 | |
| Nov. 16, 2021 | CEO | 23,000 | $12.28 | Buy | $282,440.00 |
Insiders are both buying and selling Centessa Pharmaceuticals PLC ADR stock.
The insider traders at Centessa Pharmaceuticals PLC ADR are: Saurabh Saha, Antoine Yver, Gregory M Weinhoff, Iqbal J Hussain, Karen M Anderson, Tia L Bush, Rubertis Francesco De, David M Chao, Medicxi Ventures Management (J, Harris Rotman, Thomas Templeman, David J Grainger, and Aaron Kantoff
The most active insider trader at Centessa Pharmaceuticals PLC ADR is Saurabh Saha with 17 trades.
Saurabh Saha has sold the most Centessa Pharmaceuticals PLC ADR stock with a total value of $11,366,904.87.
Rubertis Francesco De has bought the most Centessa Pharmaceuticals PLC ADR stock with a total value of $2,319,537.94.
The most recent insider trade for Centessa Pharmaceuticals PLC ADR was on March 25, 2025.
The single biggest insider buy for Centessa Pharmaceuticals PLC ADR was from Rubertis Francesco De with a total value of $761,036.48 on Dec. 1, 2021.
The single biggest insider sell for Centessa Pharmaceuticals PLC ADR was from Saurabh Saha with a total value of $2,891,000.00 on Sept. 10, 2024.